BOZEMAN, Mont.--(BUSINESS WIRE)--Golden Helix, Inc. today announced that psychiatric researchers at the Zucker Hillside Hospital, working in collaboration with Golden Helix, Inc., have developed a novel analytic method, termed whole genome homozygosity association (WGHA). Powered by Golden Helix’s HelixTree software, WGHA was recently used to identify nine genetic risk factors associated with schizophrenia, a debilitating disease that affects nearly one in every 100 people. Accepted for publication by the journal, Proceedings of the National Academy of Sciences, the study detailing the methods and findings appeared online December 5, 2007.
